Fred Andy Broadway III

2016

In 2016, Fred Andy Broadway III earned a total compensation of $628.6K as President, BioTel Heart at BioTelemetry, a 11% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$145,000
Option Awards$85,587
Salary$291,000
Stock Awards$85,585
Other$21,467
Total$628,639

Broadway received $291K in salary, accounting for 46% of the total pay in 2016.

Broadway also received $145K in non-equity incentive plan, $85.6K in option awards, $85.6K in stock awards and $21.5K in other compensation.

Rankings

In 2016, Fred Andy Broadway III's compensation ranked 10,360th out of 14,075 executives tracked by ExecPay. In other words, Broadway earned more than 26.4% of executives.

ClassificationRankingPercentile
All
10,360
out of 14,075
26th
Division
Services
1,713
out of 2,285
25th
Major group
Health Services
170
out of 209
19th
Industry group
Miscellaneous Health And Allied Services, Not
28
out of 32
13th
Industry
Specialty Outpatient Facilities, Not Elsewhere Classified
14
out of 14
0th
Source: SEC filing on March 22, 2018.

Broadway's colleagues

We found four more compensation records of executives who worked with Fred Andy Broadway III at BioTelemetry in 2016.

2016

Joseph Capper

BioTelemetry

Chief Executive Officer

2016

Heather Getz

BioTelemetry

Chief Financial Officer

2016

Daniel Wisniewski

BioTelemetry

Senior Vice President, Technical Operations

2016

Peter Ferola

BioTelemetry

General Counsel

News

You may also like